HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Capuzzi, D. M. Articles by Freeman, J. S. Search for Related Content PubMed Articles by Capuzzi, D. M. Articles by Freeman, J. S. Related Collections Related Article Social Bookmarking                What's this?

C-Reactive Protein and Cardiovascular Risk in the Metabolic Syndrome and Type 2 Diabetes: Controversy and Challenge

IN BRIEF

Although recent findings link high levels of C-reactive protein (CRP) with occurrence of future cardiovascular events, views about its biological activity and predictive value vary. The conditions under which CRP indicates or mediates inflammatory processes remain undefined. Much evidence indicates that inflammation may drive the development of insulin resistance, type 2 diabetes, and the progression of atherosclerosis. The interaction among various cytokines and cell types in these pathogenic processes remains unclear. Thus, the indications for CRP measurement for risk prediction and disease surveillance steadily evolve.

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

Related Article:

Diabetes and C-Reactive Protein

Tom Elasy
Clin. Diabetes 2007 25: 1-2. [Extract] [Full Text] [PDF]